These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9792304)

  • 1. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases.
    Hernández JM; Gutiérrez NC; Almeida J; García JL; Sánchez MA; Mateo G; Ríos A; San Miguel JF
    Br J Haematol; 1998 Oct; 103(1):163-7. PubMed ID: 9792304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis.
    Laï JL; Zandecki M; Mary JY; Bernardi F; Izydorczyk V; Flactif M; Morel P; Jouet JP; Bauters F; Facon T
    Blood; 1995 May; 85(9):2490-7. PubMed ID: 7537117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques.
    Smadja NV; Louvet C; Isnard F; Dutel JL; Grange MJ; Varette C; Krulik M
    Br J Haematol; 1995 Jul; 90(3):619-24. PubMed ID: 7647003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method.
    Brigaudeau C; Trimoreau F; Gachard N; Rouzier E; Jaccard A; Bordessoule D; Praloran V
    Br J Haematol; 1997 Mar; 96(3):594-600. PubMed ID: 9054668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
    Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
    Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation.
    Nilsson T; Lenhoff S; Turesson I; Rylander L; Mitelman F; Westin J; Höglund M; Johansson B
    Eur J Haematol; 2002 Jun; 68(6):345-53. PubMed ID: 12225392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-kit ligand (SCF) in human multiple myeloma cells.
    Lemoli RM; Fortuna A
    Leuk Lymphoma; 1996 Feb; 20(5-6):457-64. PubMed ID: 8833403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The cytogenetic and molecular genetic study of 81 multiple myeloma patients].
    Li JT; Chang NB; Liu H; Pei L
    Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1039-42. PubMed ID: 22333174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients.
    Facon T; Lai JL; Nataf E; Preudhomme C; Zandecki M; Hammad M; Wattel E; Jouet JP; Bauters F
    Br J Haematol; 1993 Aug; 84(4):743-5. PubMed ID: 8217836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Bender JG; Unverzagt KL; Maples PB; Mehrotra Y; Mellon J; Van Epps DE; Stewart CC
    Exp Hematol; 1992 Oct; 20(9):1135-40. PubMed ID: 1361455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitro.
    Millar BC; Bell JB; Millar JL; Treleaven J; Montes A; Joffe JK; Powles RL; McElwain TJ
    Exp Hematol; 1992 Feb; 20(2):209-15. PubMed ID: 1371966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
    Jelinek DF; Ahmann GJ; Greipp PR; Jalal SM; Westendorf JJ; Katzmann JA; Kyle RA; Lust JA
    Cancer Res; 1993 Nov; 53(21):5320-7. PubMed ID: 8221668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
    Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
    J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
    Estrov Z; Markowitz AB; Kurzrock R; Wetzler M; Kantarjian HM; Ferrajoli A; Gutterman JU; Talpaz M
    Leukemia; 1993 Feb; 7(2):214-20. PubMed ID: 8426475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic studies of non-lymphocytic neoplasias using hematopoietic growth factors: GM-CSF provides pronounced mitotic increase and improvement of the quality of banded chromosomes compared to G-CSF.
    Nakamura H; Sasagawa I; Itoyama T; Mine M; Amenomori T; Sadamori N; Tomonaga M
    Leukemia; 1993 Sep; 7(9):1471-5. PubMed ID: 7690442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors.
    Van den Berg E; Van Oven MW; de Jong B; Dam A; Wiersema J; Dijkhuizen T; Hoekstra HJ; Molenaar WM
    Lab Invest; 1994 Mar; 70(3):307-13. PubMed ID: 8145525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.